Clinical Trial Update: Heart Rate Variability Biofeedback for Smoking Cessation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial examining heart rate variability biofeedback as a strategy to aid smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation
• Tobacco Use Disorder

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Tobacco Smoking | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25